Reacts with the "cytolytic T lymphocyte associated antigen" CTLA-4. CTLA-4 is transiently expressed on activated CD28+ T cells and binds to CD80 and CD86 present on antigen presenting cells (APC) with high avidity. This interaction appears to deliver a negative regulatory signal to the T cell. There are recent reports which indicate that CTLA-4 is also expressed on B cells when cultured with activated T cells suggesting a possible role of CTLA-4 in the regulation of B cell response.
REFERENCES
1. Lindsten, T., K. P. Lee, E. S. Harris,
et al.
1993. Characterization of CTLA-4 structure and expression on human T cells.
J. Immunol
151: 3489.
2. Kuiper, H. M., M. Brouwer, P. S. Linsley,
et al.
1995. Activated T cells can induce high levels of CTLA-4 expression on B cells.
J. Immunol.
155: 1776.
3. Morton, P. A., X-T. Fu, J. A. Stewart,
et al.
1996. Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2).
J. Immunol.
156: 1047.
4. Barclay, N. A., M. L. Birkeland, M. H. Brown,
et al.
1993. The Leucocyte Antigen Facts Book. p. 290. Academic Press.
| Cat. No. | Description | Clone | Isotype | Size |
| 34581A | Purified anti-human CTLA-4 | BNI3.1 | Mouse IgG2a | 0.1mg |
| 34582X | Biotinylated anti-human CTLA-4 | BNI3.1 | Mouse IgG2a | 100 tests |
PharMingen also supplies a number of antibodies for studies in cell interaction, including:
![]() |
![]() |
![]() |
![]() |